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Abstract
Parasitism creates selection for resistancemechanisms in host populations and is hypothesized to promote increased host
evolvability. However, the influence of these traits on host evolution when parasites are no longer present is unclear. We
used experimental evolution and whole-genome sequencing of Escherichia coli to determine the effects of past and
present exposure to parasitic viruses (phages) on the spread of mutator alleles, resistance, and bacterial competitive
fitness. We found that mutator alleles spread rapidly during adaptation to any of four different phage species, and this
pattern was even more pronounced with multiple phages present simultaneously. However, hypermutability did not
detectably accelerate adaptation in the absence of phages and recovery of fitness costs associated with resistance. Several
lineages evolved phage resistance through elevated mucoidy, and during subsequent evolution in phage-free conditions
they rapidly reverted to nonmucoid, phage-susceptible phenotypes. Genome sequencing revealed that this phenotypic
reversion was achieved by additional genetic changes rather than by genotypic reversion of the initial resistance muta-
tions. Insertion sequence (IS) elements played a key role in both the acquisition of resistance and adaptation in the
absence of parasites; unlike single nucleotide polymorphisms, IS insertions were not more frequent in mutator lineages.
Our results provide a genetic explanation for rapid reversion of mucoidy, a phenotype observed in other bacterial species
including human pathogens. Moreover, this demonstrates that the types of genetic change underlying adaptation to
fitness costs, and consequently the impact of evolvability mechanisms such as increased point-mutation rates, depend
critically on the mechanism of resistance.
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Introduction
Infectious parasites create evolutionary pressure for resistance
mechanisms in their hosts (Schmid-Hempel 2011) and indi-
rectly select for mechanisms that generate genetic and phe-
notypic diversity (Hamilton et al. 1990; Zaman et al. 2014).
Bacterial infection by viruses (phages) is the most common
host–parasite interaction on Earth, globally estimated at 1025
infections per second (Pedulla et al. 2003), and diverse phage-
resistance mechanisms have been characterized (Labrie et al.
2010). Phage selection can also cause alleles that modify bac-
terial mutation rates to spread through genetic hitchhiking,
because resistance mutations are produced more frequently
in mutator lineages (Pal et al. 2007; Morgan et al. 2010;
O’Brien et al. 2013). Both resistance and mutator alleles
have important effects on bacterial evolutionary trajectories
(Wielgoss et al. 2013; Scanlan et al. 2015), medical outcomes
by altering bacterial growth rate and virulence (Smith and
Huggins 1982; Capparelli et al. 2010), and antibiotic resistance
(Oliver et al. 2000; Denamur et al. 2002). However, it remains
unclear how traits acquired under parasitism, including phage
resistance and hypermutability, will influence evolution in the
absence of parasites. This question is key to understanding
the long-term effects of parasitism: Parasite densities and rates
of infection, including those of phages (Weinbauer 2004), are
inherently variable in space and time, particularly following
the evolution of host resistance (Sasaki 2000). Therefore, a full
understanding of how parasitism influences host evolution
requires that we account for not only resistance evolution but
also subsequent adaptation in parasite-free conditions.
Bacteria can readily adapt to recover fitness defects
associated with both phage- (Lenski 1988b) and antibiotic-
resistance (Schrag et al. 1997; Maisnier-Patin and Andersson
2004). Experiments with antibiotic-resistant bacteria indicate
that mutator alleles can accelerate this process (Perron et al.
2010), but it is not known whether this is also true for phage
resistance. Crucially, we can predict that compensatory mech-
anisms, and potentially the effects of hypermutability, will
depend on the original mechanism of resistance. For example,
many antibiotics target essential enzymes, and consequently
resistance is often due to mutations that alter the structure of
these enzymes (Walsh 2000; Blair et al. 2014). When antibi-
otics are removed, adaptation to recover the cost of resistance
is constrained to mutations that maintain the structure and
function of the antibiotic target. Typically such mutations
occur at specific sites on the enzyme that was originally mu-
tated or subunits that interact with it, and do not restore
antibiotic sensitivity (Maisnier-Patin and Andersson 2004;
Andersson and Hughes 2011; Brandis et al. 2012). Perron
et al. (2010) showed that mutator alleles can accelerate this
process for rifampicin-resistant bacteria. In contrast, costs
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associated with some phage-resistance mechanisms, such as
modification of cell surface structures or secretion of extra-
cellular polysaccharides (Labrie et al. 2010), may rely on dif-
ferent types of genetic changes. For example, there are many
genes involved in synthesis and secretion of extracellular poly-
saccharides (Stevenson et al. 1996; Muhammadi and Ahmed
2007). Consequently, there may be a relatively broad range of
genetic changes, including reduction- or loss-of-function mu-
tations, that can both downregulate the costly expression of
extracellular products and, unlike in the example of rifampicin
resistance above, reverse resistance. In this case, if adaptation
is not limited by the supply of beneficial mutations, then
mutator alleles will not necessarily accelerate this process
(Tenaillon et al. 1999). Therefore, the genetic mechanisms
of adaptation following exposure to viral parasites and the
impact of mutator alleles may deviate from previous obser-
vations with antibiotic-resistant bacteria and depend critically
on the original mechanism of resistance.
We addressed these questions using experimental popula-
tions of E. coli and lytic phages. We manipulated bacterial
mutability by use of a mutator genotype that has defective
DNA mismatch repair, the same mechanism that confers
increased mutability in clinical isolates of several other species
including human pathogens (LeClerc et al. 1996; Chopra et al.
2003; Li et al. 2003; Jolivet-Gougeon et al. 2011). We first
tested whether increased mutation rate was advantageous
in the presence of each of four phages, both alone and in
combinations. We then propagated different types of phage-
resistant mutants, derived from mutator and nonmutator
genetic backgrounds, in the absence of phages for approxi-
mately 66 generations. We included phage treatments where
the major resistance mechanisms are known to involve cell-
surface modification and increased secretion of extracellular
polysaccharide (mucoidy), both of which have been observed
in several other bacterial species including pathogens
(Bohannan and Lenski 2000; Mizoguchi et al. 2003; Labrie
et al. 2010; Scanlan and Buckling 2012; Cremet et al. 2013).
This strategy, summarized schematically in supplementary
figure S1, Supplementary Material online, allowed us to test
four hypotheses: 1) Increased mutation rate is advantageous
in the presence of different bacteriophages, both alone and in
combinations; 2) mutator populations that have evolved re-
sistance to phages adapt more effectively in phage-free con-
ditions than nonmutators that have evolved resistance to the
same phage treatment; 3) fitness recovery in the absence of
phages depends on the initial mechanism of resistance; and 4)
the genetic basis of adaptation depends on both bacterial
mutation rate and the initial mechanism of parasite
resistance.
Results
Mutator Advantage in the Presence of Parasites
We tested whether an increased mutation rate was advanta-
geous in the presence or absence of parasites by competing a
mutator and nonmutator strain (hereafter denoted “Mut” for
Mutator and “Ref” for Reference, respectively) in experimen-
tal conditions with and without phages (supplementary
fig. S1, Supplementary Material online). We included four
different phages, both alone and in each pairwise combina-
tion, to determine whether mutator alleles have similar effects
across different parasite treatments. The likelihood of the
mutator spreading varied among phage treatments (F10,33 =
6.26, P < 0.0001; fig. 1): The average selection coefficient for
the mutator in each phage treatment was greater than in the
phage-free control, and was on average greater in two-phage
treatments than single-phage treatments (Welch’s t5.78 = 4.49,
P = 0.005). In addition, the mutator was the only genetic
background to survive phage selection in 4 of 16 populations
from single-phage treatments and 22 of 24 populations from
two-phage treatments. In the populations where the mutator
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FIG. 1. Mutator advantage in the presence of phages. Each circle represents a single population (n = 4 in each treatment); bars show the average
selection coefficient for the mutator relative to a marked version of the reference strain (K-12 MG1655 ara).
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did not completely fix, we note that it is possible the
Reference would eventually also evolve phage resistance
and increase in frequency.
Mutator advantage was associated with the spread of
phage-resistance alleles (supplementary fig. S2,
Supplementary Material online). In streaking assays, the
colony isolates from two-phage treatments were on average
resistant to 2.87 (SE = 0.08) of the four tested phages, whereas
colony isolates from one-phage treatments were resistant to
only 1.04 (SE = 0.08) phage on average, typically the one they
were exposed to during selection (supplementary fig. S2,
Supplementary Material online). This can be explained by
the frequency of mucoid phage-resistant mutants in the dif-
ferent treatments: 52 of the 196 colony isolates had a mucoid
morphology, 48 of which were from two-phage treatments,
and every mucoid isolate was resistant to all four phages. No
isolates from the phage-free treatment were resistant to any
phage.
Reversion of Phage Resistance in the
Absence of Phages
To determine whether mutator bacteria also adapted rela-
tively rapidly during subsequent evolution in the absence of
phages, and whether any effects depended on the original
mechanism of phage resistance, we isolated three mucoid
and three nonmucoid phage-resistant mutants on both the
mutator and nonmutator genetic backgrounds (all from the
+T4 treatment, because this treatment consistently pro-
duced a mixture of mucoid and nonmucoid isolates; supple-
mentary fig. S2, Supplementary Material online). We then
propagated these 12 isolates for 10 growth cycles in the ab-
sence of phages. Mucoid isolates all rapidly reverted to both
phage-sensitivity (quantified in liquid culture; fig. 2) and non-
mucoidy (nonmucoid colonies on agar; fig. 3). Reversion was
rapid in both mutator and nonmutator genetic backgrounds,
and the rate of decline in resistance did not differ on average
between mutator and nonmutator selection lines that were
initially mucoid (time  mutability interaction in a linear
mixed-effects model of resistance averaged across all selection
lines derived from each ancestral isolate at each time point,
with time as a covariate, mutability [Mut or Ref] as a fixed
effect, and ancestral isolate as a random effect: F1,28 = 1.50,
P = 0.23). Populations derived from nonmucoid phage-resis-
tant isolates remained resistant to phages on average (effect
of time in a mixed model as above: F1,28 = 2.48, P = 0.13; fig. 2),
although for one mutator ancestral isolate all three selection
lines declined in resistance over time but did not revert to full
sensitivity. Colony isolates chosen randomly from evolved
populations showed the same qualitative result (supplemen-
tary fig. S3, Supplementary Material online), and we con-
firmed that phage sensitivity measured in liquid culture
corresponded to sensitivity in streaking assays as used at
the end of competition experiments above.
We also tested whether reversion of mucoidy during evo-
lution in the absence of phages altered the likelihood of re-
evolving a mucoid phenotype during subsequent re-exposure
to the same phage treatment. Bacteria that were derived from
mucoid ancestors but had reverted to nonmucoidy and
phage sensitivity during evolution in phage-free conditions
did not produce any mucoid mutants upon subsequent re-
exposure to phages (supplementary fig. S4, Supplementary
Material online). In contrast, three out of six reference pop-
ulations from the same conditions contained mutants form-
ing mucoid colonies (supplementary fig. S4, Supplementary
Material online). Therefore, reversion of mucoidy constrains
subsequent evolution of this phenotype.
Recovery of Fitness Costs Associated
with Phage Resistance
We measured fitness relative to the ancestor for the 12 phage-
resistant colony isolates (three mucoid and three nonmucoid
for both Mut and Ref) and a single colony isolate derived
from each one after evolution in the absence of phages; we
used the same 24 isolates for whole-genome sequencing de-
scribed below. Our rationale for focusing on single genotypes
rather than whole populations was, following Scanlan et al.
(2015), to directly link phenotypic data (fitness and resis-
tance) with genomic information (see below); this approach
provided multiple independently evolved genotypes in each
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FIG. 2. Changes in phage resistance on genetic backgrounds that were
initially nonmucoid (solid lines) or mucoid (dashed lines) with (A)
normal or (B) elevated mutation rates. Each series shows a single
phage-resistant mutant isolated after exposure to phages  and T4
(T0; phage presence denoted by hatching at left), and then maintained
in the absence of phages for ten transfers. Each point shows the average
(+SE) resistance score for three independent selection lines. Labels at
right denote the six independent phage-resistant isolates sampled from
reference (Ref) and mutator (Mut) strains. Note that at transfer 0 each
selection line was bottlenecked to a single colony isolate.
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combination of the categories we were interested in (ances-
tral/evolved, mucoid/nonmucoid, mutator/nonmutator). In
the absence of phages, resistance was costly on average on
both Mut and Ref genetic backgrounds prior to experimental
evolution in phage-free conditions (mean fitness SD = 0.89
 0.08 and 0.92  0.15, respectively; fig. 4), although fitness
varied among different isolates, including one with no cost.
After evolution in the absence of phages, the isolates derived
from the 12 ancestral genotypes all showed fitness values
larger than or not significantly different from the reference
strain (fig. 4), indicating that costs of resistance can be rapidly
recovered.
We found no difference on average between the fitness of
isolates derived from mutator and nonmutator genetic back-
grounds (F1,9 = 0.21, P = 0.67 in a mixed model with fitness as
the response, mucoidy and mutability as fixed effects, and
ancestral isolate as a random effect). However, average fitness
of evolved isolates that were initially mucoid was higher on
average than that of isolates derived from nonmucoid ances-
tors (F1,9 = 11.31, P = 0.008). In other words, mutation rate did
not strongly impact the outcome of evolution in terms of
changes in resistance and competitive fitness, but the original
phage-resistance phenotype (mucoid or nonmucoid) did.
Note that the two ancestral phage-sensitive genetic back-
grounds from which phage-resistant mutants were derived
can adapt to these experimental conditions over this
time-scale (supplementary fig. S5, Supplementary Material
online). Therefore, the increased fitness of evolved isolates
may reflect a combination of adaptation to recover the
cost of phage resistance and general adaptation to the exper-
imental environment. The response to selection (change in
fitness) was greater on average for phage-resistant genetic
backgrounds than that observed for control selection lines
(mean SD = 0.24 0.16 compared with 0.11 0.09; one-
sample t11 = 2.76, P < 0.02), consistent with compensatory
evolution (Moore et al. 2000; Hall et al. 2010).
Parallel Genetic Changes Acquired in the
Presence of Phages
Whole-genome sequencing showed that every mucoid
phage-resistant isolate had a genetic change in a locus in-
volved in colanic acid biosynthesis (figs. 5 and 6; supplemen-
tary table S1, Supplementary Material online, at time point
T0): Two had single nucleotide polymorphisms (SNPs) in rcsC,
encoding a sensory kinase controlling capsule biosynthesis,
and four had SNPs or insertion sequence (IS) insertions in
or upstream of yrfF, encoding a putative response attenuator
of the RcsCDB system in which this type of genetic change is
known to cause mucoidy (Miskinyte et al. 2013). We
also detected strong parallelism among nonmucoid phage-
resistant mutants: Five out of six had mutations affecting the
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FIG. 3. Changes in mucoidy during evolution in the absence of phages
for (A) reference and (B) mutator lineages. Mucoidy was scored as the
proportion of colonies with a mucoid phenotype in each selection line
(three selection lines per mucoid phage-resistant ancestor; each line is
labelled with the corresponding ancestral isolate). Each point shows the
average  SE from three independent selection lines.
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FIG. 4. Changes in competitive fitness during evolution in the absence
of phages. Competitive fitness was measured in the absence of phages
for three nonmucoid (left panels) and three mucoid (right panels)
phage-resistant isolates derived from (A) the reference and (B) mutator
strains. Symbols represent each of the three independent isolates sam-
pled in each case (as in figs. 2 and 3). Each point shows the average SE
of three independent assays for a single colony isolate.
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coding region or transcription activation site of ompC,
encoding the outer membrane protein C (OmpC), known
to confer phage resistance (Yu and Mizushima 1982). One
of these mutations was an IS5-mediated 23-kb deletion
(supplementary table S1, Supplementary Material online; lin-
eage Mut3), which included both ompC and rcsD. The other
nonmucoid resistant mutant had two mutations that may
also be linked to phage resistance by the same mechanism
FIG. 5. Representation of evolved mutations along the whole genomes of single colony isolates sampled at different time points (T) in reference (Ref)
and mutator (Mut) lineages and derived from both (A; green symbols) nonmucoid and (B; red symbols) mucoid ancestors. Gray areas highlight regions
of parallel evolution as described in the main text. Symbols depict the six mutational categories.
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(supplementary table S1, Supplementary Material online; lin-
eage Ref3): A nonsynonymous SNP in the coding region of
envZ, which encodes the sensor EnvZ known to alter the
expression of OmpC through the response regulator OmpR
(Wandersman et al. 1980; Garrett et al. 1983; Slauch et al.
1988), and a frameshift mutation after an insertion of G
into the coding region of manZ. The manZ gene encodes a
subunit of the maltose permease, a gateway for phage  to
enter the host cytosol from the periplasm (Erni et al. 1987;
Esquinas-Rychen and Erni 2001), and is known to be involved
in phage-resistance evolution (Meyer et al. 2012). We tested
for altered phage susceptibility in knockouts of these genes
from the Keio collection (Baba et al. 2006), finding that, as
expected from earlier studies (Wandersman et al. 1980; Yu
and Mizushima 1982), the OmpC knockout was relatively
resistant to T4 and the T4+ combination (supplementary
fig. S6, Supplementary Material online); the EnvZ knockout
was relatively resistant to T4, but deleting ManZ did not have
a strong effect on phage resistance in liquid culture on its
own. Thus, OmpC and EnvZ mutations can be linked to
phage resistance, whereas any benefit of ManZ mutation in
liquid may be contingent on the EnvZ mutation that we
found on the same genome.
Parallel Genetic Changes Driving Adaptation and
Reversion of Mucoidy
All six isolates derived from mucoid ancestors, which reverted
to nonmucoid phage-sensitive phenotypes in the absence of
phages, had acquired additional changes in rcsD, rcsB or rcsC
and retained their original mutations (figs. 5B and 6B; supple-
mentary table S1, Supplementary Material online). For two of
these genotypes, clonal isolates from the same populations at
an earlier time point (transfer 2) had the same genetic change
in this region (Ref6: IS insertion in rcsC; Mut5: SNP in rcsB),
indicating that these changes appeared early and were main-
tained. For two other genotypes, isolates sampled from the
same populations at transfer 2 had genetic changes in regions
that were subsequently deleted in the isolates sampled at
transfer 10 (Ref4: IS insertion in rcsD followed by large dele-
tion; Mut6: small deletion [64 bp] in rcsC followed by a 14-kb
deletion spanning the entire region including all three rcs-
genes). In these populations the later genetic change could
have occurred on a genome that already had the first genetic
change, or on a competing lineage derived from the same
ancestor. The latter scenario is consistent with our observa-
tions in the remaining two populations derived from mucoid
ancestors: The genetic change observed at transfer 2 was not
present at transfer 10 (Ref5: insertion in rcsD at transfer 2 and
deletion in rcsD at transfer 10; Mut4: insertion in rcsB at
transfer 2 and deletion in rcsC at transfer 10). Thus, reversion
of mucoidy in mutator and nonmutator lineages was always
associated with alterations of rcs (table 1), and in some pop-
ulations we detected independent revertant lineages at dif-
ferent time points.
Isolates derived from nonmucoid resistant genotypes also
retained their original mutations, in genes affecting ompC or
manZ (supplementary table S1, Supplementary Material
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FIG. 6. Position of genetic changes associated with phage resistance and reversion of mucoidy in genes for which high parallelism was detected.
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online), and acquired additional genetic changes. Unlike for
isolates derived from mucoid genotypes, there was little evi-
dence for parallelism, except for IS movements in the coding
sequence of fimE, a regulator involved in phase variation of
type 1 fimbriation, and either of its two flanking intergenic
regions, which we found in four out of six genotypes. We also
found IS mutations in this region in five out of six genotypes
derived from mucoid ancestors, indicating that they had a
beneficial function across the different genetic backgrounds
in our experimental conditions. In support, when we se-
quenced this region for six independently evolved control
isolates, which had never been exposed to phages but
adapted to the same phage-free conditions (3  Ref; 3 
Mut; supplementary fig. S5, Supplementary Material online),
we found genetic changes in this region in all six isolates
(supplementary table S3, Supplementary Material online),
three of which were IS movements. Mutations in genes reg-
ulating the expression of fimbrial proteins, including IS inser-
tions into fimA and fimB genes, have also been previously
detected during adaptation to laboratory media in E. coli
(Barrick et al. 2009; Winkler et al. 2014).
Mutator Effect Is Limited to SNPs
The presence of the mutator allele had a strong impact on
genetic diversity during the initial period of phage-resistance
evolution (table 1; Welch’s t-test on total number of genetic
changes in mutator and reference genotypes: t6.5 = 3.6,
P = 0.01). This effect was driven by a difference in the average
number of SNPs (mutator: 5.7, SD = 3.1; reference: 0.8, SD =
0.4; P = 0.01), and is not significant when SNPs are excluded (P
= 0.6). Genotypes derived from the mutator also had more
SNPs after evolution in phage-free conditions (7.3, SD = 3.3
compared with 0.83, SD = 0.4 for the reference; P = 0.005), but
there was no significant difference in the total number of
other types of genetic changes (P = 0.45). Of all SNPs in
coding regions, four out of four were nonsynonymous in
Reference isolates and 26 out of 37 were nonsynonymous
in Mutator isolates (supplementary table S4, Supplementary
Material online). In summary, lineages with defective DNA
mismatch repair acquired more SNPs, and this was advanta-
geous in the presence of phages. However, during subsequent
evolution in the absence of phages other types of genetic
changes, mostly IS insertions (table 1), were relatively more
important and our phenotypic analyses showed that mutator
lineages did not adapt or revert costly phenotypes more
rapidly.
Discussion
Returning to our four hypotheses, we found that 1) elevated
bacterial mutation rate was highly advantageous in the pres-
ence of parasitic viruses, and particularly in multiparasite
treatments; 2) elevated mutation rate did not detectably
accelerate adaptation to or reversion of costly parasite-
resistance phenotypes in the absence of phages, unlike obser-
vations with costly antibiotic-resistance phenotypes (Perron
et al. 2010); 3) changes in bacterial fitness and the likelihood of
reversion to phage sensitivity were dependent on the initial
mechanism of phage resistance. Phage resistance here, as in
other experiments with E. coli (Hancock and Reeves 1975;
Bohannan and Lenski 2000; Mizoguchi et al. 2003; Kim et al.
2015) and other bacterial species (Ohshima et al. 1988; Labrie
et al. 2010; Scanlan and Buckling 2012), typically resulted from
modification of cell surface receptors (OmpC) or mucoidy
owing to mutations in genes involved in extracellular poly-
saccharide biosynthesis (rcs genes). Both mucoid and nonmu-
coid phage-resistance mutants paid a cost in competitive
fitness in the absence of phages, but rapidly recovered
during evolution in phage-free conditions, attaining similar
fitness to phage-sensitive controls. Nonmucoid resistant mu-
tants maintained resistance in the absence of phages, as ob-
served with E. coli B (Lenski 1988b). However, for mucoid
mutants, which do not form in E. coli B (Lenski 1988a), adap-
tation was associated with rapid reversion to nonmucoidy
and phage sensitivity. The lack of mucoid mutants in E. coli
B probably results from the complete lack of rcsA-D, attrib-
utable to IS-mediated deletions (Studier et al. 2009). 4) Our
sequence data showed that the genetic basis of adaptation
was strongly related to the initial mechanism of phage resis-
tance: Reversion of mucoidy occurred through diverse SNPs,
IS insertions and deletions, but always in rcs genes; mutations
in this region were not observed in lineages derived from
nonmucoid ancestors.
Why is mucoidy so reversible? Mucoidy evolves in the
presence of phages and is associated with a large mutational
target including many genes involved in colanic acid biosyn-
thesis and regulation (Gottesman et al. 1985; Costa and
Anton 2001; Ionescu and Belkin 2009). As such, there are
many mutational pathways to a mucoid phenotype
(Lieberman and Markovitz 1970; Ophir and Gutnick 1994).
Table 1. Summary of Genetic Changes in Mutator and Nonmutator Lineages.
Time (transfer) Mutator Mucoid Ancestor SNPs Insertions Deletions Big Deletions IS Insertions Duplications Total
0 No No 1  0 0.3  0.6 0  0 0.7  1.2 0.7  0.6 0.3  0.6 3  1
0 No Yes 0.7  0.6 0  0 0  0 0  0 0.3  0.6 0  0 1  0
0 Yes No 5  4.6 0  0 0.7  0.6 0.3  0.6 0  0 0  0 6  4.6
0 Yes Yes 6.3  1.5 1.7  1.5 0.3  0.6 0  0 0  0 0  0 8.3  1.2
10 No No 1  0 0.3  0.6 0  0 1  1 1.7  0.6 0.7  0.6 4.7  0.6
10 No Yes 0.7  0.6 0  0 0  0 0.7  0.6 1.7  0.6 0  0 3  0
10 Yes No 6.3  4.9 0.7  1.2 0.7  0.6 0.3  0.6 1.3  0.6 0  0 9.3  4.5
10 Yes Yes 8.3  0.6 2  1.7 0.3  0.6 0.7  0.6 1  1 0.3  0.6 13  2.5
NOTE.—Each value is the mean number of changes  SD for three independent genotypes.
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In agreement with our findings, Costa and Anton (2001) and
Scanlan and Buckling (2012) noted that mucoidy is unstable:
Revertants are often observed during routine laboratory cul-
ture. Our results suggest that such reversibility may be due to
a large mutational target for reversion of mucoidy: Although
there was strong parallelism in that every revertant genotype
had acquired a mutation in an rcs gene, this included SNPs, IS
insertions and deletions across three different genes.
Consistent with this, in some populations we detected inde-
pendent revertant genotypes derived from the same mucoid
ancestor at different time points. This large mutational target
may also partially explain why mutator lineages did not revert
faster than nonmutator lineages. Evidently the supply rate of
mutations affecting mucoidy is sufficient for nonmutator
populations of this size (~109 at stationary phase) to contain
at least one reversion mutation at the start of the experiment.
In agreement, our own and previous estimates for rates of
spontaneous mutation and IS movements suggest that
genetic changes conferring and reversing mucoidy were
abundant, respectively, during and after phage exposure
(Wielgoss et al. 2011; Sousa et al. 2013; Supplementary data,
Supplementary Material online). Moreover, the fact that re-
version was often due to IS mutations or deletions which,
unlike SNPs, were not more frequent on the mutator genetic
background compared with the reference, suggests that the
increased genetic diversity in mutator lineages is limited to
SNVs (single nucleotide variants). When adaptation relies on
other types of genetic changes an SNV mutator, such as our
mutS-defective strain, does not gain an indirect fitness advan-
tage due to increased evolvability.
The rapid reversibility of mucoidy is also relevant in other
contexts. Mucoid isolates are often recovered from chronic
infections caused by key pathogens including E. coli and
Pseudomonas aeruginosa (Doggett 1969; Ciofu et al. 2001;
Cremet et al. 2013). In P. aeruginosa, where the genetic
basis of mucoidy is different to E. coli, mutations resulting
in constitutive mucoidy appear to be involved in adaptation
to host immune responses during early stages of chronic in-
fection (Yang et al. 2012; Marvig et al. 2015). However,
mucoidy can subsequently be repressed by mutations at
other sites, hypothesized to result from adaptation to regulate
costly expression of this phenotype (Marvig et al. 2015). More
generally, mucoidy can also alter bacterial adaptation to other
diverse stresses including antibiotics (Pi~na and Mattingly
1997), macrophages (Miskinyte et al. 2013), menthol
(Landau and Shapira 2012), and dessication (Ophir and
Gutnick 1994). Therefore, we speculate that acquisition of
mucoidy and regulation of associated costs, as observed in
our experiments, may be common features of bacterial
adaptation.
We found strong parallelism in the types of mutations
responsible for acquiring mucoidy and phage resistance, re-
versing mucoidy, and adaptation to the experimental abiotic
environment. This is consistent with previous experimental
studies showing variable but pervasive genetic parallelism in
adaptation to novel environments (Tenaillon et al. 2012;
Bailey et al. 2015) and stressors such as antibiotics (Vogwill
et al. 2014), as well as comparative studies of clinical isolates of
human pathogens (Lieberman et al. 2011; Marvig et al. 2015).
This indicates that genetic parallelism can result from adap-
tation of independent populations to identical, strong selec-
tion pressures, such as antibiotics and parasites, as well as
selection for improved growth in a benign abiotic environ-
ment, although in many cases parallelism is manifest at the
level of genes, rather than individual genetic changes (Woods
et al. 2006; Barrick et al. 2009).
Why are other types of resistance less reversible? Resistance
through modification of OmpC, or phage receptors in gen-
eral, can probably only be reverted by regaining the original
and functional three-dimensional structure of the phage re-
ceptor, which may only be possible by a reversion to the
ancestral sequence of this gene. Thus, the mutational target
size for reversion probably equals 1 when resistance is due to
receptor modification. In a more extreme scenario, when the
receptor is deleted it may be impossible to restore receptor
function in a single step (or without horizontal gene transfer).
Consistent with the low reversibility of resistance to T4 in
nonmucoid E. coli, Lenski (1988b) found that resistance was
maintained in the absence of phages for 400 generations in
E. coli B. The same rationale has also been used to explain
why compensatory adaptation to costs of antibiotic resis-
tance is more likely to occur through mutations at other
loci than by reversion of the initial resistance mutation
(Levin et al. 2000; Maisnier-Patin and Andersson 2004):
Many mutations can restore or compensate for the function
impaired by resistance mutations, but only one mutation may
restore antibiotic-target binding specificity. In contrast,
mucoidy can be reversed by any mutation that reduces bio-
synthesis or secretion of extracellular polysaccharide, includ-
ing large deletions as observed in our experiment. Therefore,
the mutational target size is much larger than one. This raises
the possibility that, in general, resistance resulting from mu-
tations on drug targets or phage receptors will have very low
rates of reversion compared with resistance due to mutations
that up- or downregulate expression of existing proteins such
as those involved in EPS biosynthesis.
Active IS elements are known to be rapid drivers of
genome evolution (Papadopoulos et al. 1999; Schneider
et al. 2000; Cooper et al. 2001). Recently, and in line with
our findings, it has been shown that IS elements can also
lead to large genome rearrangements, including deletions,
owing to homologous recombination events between identi-
cal elements during experimental evolution (Raeside et al.
2014). Our results suggest that such events can contribute
to recovery of fitness costs associated with resistance mech-
anisms in the absence of phages. Thus, although IS elements
may impose a genetic burden by causing deleterious changes
(Touchon and Rocha 2007), they can also cause adaptive
changes in some scenarios (Chou et al. 2009; Stoebel and
Dorman 2010; Gaffe et al. 2011), in this case by allowing rel-
atively rapid adjustment of expression of energetically costly
proteins. Together with our other results, this suggests bac-
terial adaptation to changing environments can be acceler-
ated by a range of diversity-generating mechanisms. These
include 1) mutator alleles as identified in clinical and natural
isolates (LeClerc et al. 1996; Matic et al. 1997; Turrientes et al.
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2010) and shown here to be advantageous in single- and
multiple-parasite environments, which are likely to be rele-
vant in nature (Koskella et al. 2012); and 2) IS elements that
our study showed to play a key role when parasites were no
longer present.
Mutator and nonmutator phage-resistant mutants in
our evolution experiment had different phage-resistance
mutations. In fact, although there was very high parallelism
at the level of genes, individual putative phage-resistance
mutations within rcsCDB, yrfF, ompC or manZ were each
found in a single isolate. Therefore, one may argue that the
failure of mutators to adapt or revert phage resistance more
rapidly than nonmutators was due to their having “hard-to-
recover-from” phage-resistance mutations in the first place.
Although we cannot exclude the possibility that a mutator
and nonmutator with identical phage-resistance mutations
would adapt at different rates, our aim was instead to test
for a difference in the outcomes of evolution in mutator
and nonmutator lineages with phage-resistance mutations
acquired during evolution in the presence of phages; that is,
realistic random draws from the spectrum of possible
phage-resistance mutations on each genetic background.
Additionally, resistance mutations were in the same genes
and had similar fitness costs, a key determinant of the rate
of adaptation (Moore et al. 2000; Sousa et al. 2012), sug-
gesting that our experimental design nevertheless captured
similar evolutionary processes in mutator and nonmutator
lineages, with multiple independent replicates for each.
Materials and Methods
Organisms and Growth Conditions
We used E. coli K-12 MG1655 grown with orbital shaking at
37 C in all experiments. Unless otherwise stated, bacteria
and phages were grown in lysogeny broth (LB) supplemented
with 10 mM MgSO4. In competition experiments in the
presence of phages and for experimental evolution in the
absence of phages, we compared the reference strain with
a conditional mutator strain that has the native mutS pro-
moter replaced by the ParaBAD promoter. Thus, ParaBAD-mutS
is repressed in the absence of arabinose, leading to an ap-
proximately 50-fold increase in mutation rate (supplemen-
tary fig. S7, Supplementary Material online). The reference
mutation rate can be restored by adding 0.2% (w/v) arabi-
nose, which induces the ParaBAD promoter, thereby activating
the expression of mutS. We exploited this feature when
growing phage-resistant colony isolates of the mutator for
freezer storage or DNA extraction, to minimize the likelihood
of additional mutations influencing our analysis of mutations
occurring during the experiment. We denote the mutator
and reference genetic backgrounds and lineages derived from
them by the prefixes “Mut” and “Ref” respectively. We used
four different lytic phages: , T4, T5, and T6. The  strain we
used is an obligate lytic strain called cI26 (Meyer et al. 2012).
Competition Experiments in the Presence of Phages
We tested whether the mutator was at an evolutionary ad-
vantage over the reference strain in the presence of each
phage (supplementary fig. S1, Supplementary Material
online), both on its own (n = 4) and in each pairwise com-
bination (n = 6). We competed the mutator against a marked
ara version of the reference. This strain is otherwise isogenic
but is distinguished by red colonies on Tetrazolium–
Arabinose (TA) agar plates. For a given competition, we
grew independent overnight cultures of the mutator and
reference, before mixing them 1:1 (v/v) and diluting
100-fold to a final volume of 1 ml in 96-deep-well plates
(ABgene, Thermo Fisher Scientific, Waltham, MA). We then
added either approximately 5  106 phage particles sus-
pended in 10ml phosphate-buffered solution (PBS), or 10ml
sterile PBS for phage-free treatments. After 24 h of growth, we
transferred an aliquot to fresh media (100-fold dilution) and
incubated for a further 24 h. We estimated the frequency of
each bacterial genetic background at 0 and 48 h by dilution
and plating on TA agar. Every competition was replicated four
times independently. We estimated the selection coefficient
for the mutator relative to the ara reference strain as s =
ln(R48h/R0h)/2, where R48h and R0h are the ratios of the two
genetic backgrounds at the start and end of the competition,
respectively (Lenski et al. 1991; Travisano and Lenski 1996),
giving the difference in Malthusian growth parameters per
day (Travisano and Lenski 1996; Lopez-Pascua and Buckling
2008; Gomez and Buckling 2013); a per-generation-estimate
in the presence of phages is precluded by the difficulty of
estimating the number of bacterial generations in these con-
ditions. In cases where only one genetic background was pre-
sent at the end of the assay, we conservatively took the final
frequency to be 0.99.
Qualitative Phage-Resistance Assays
To determine whether phage-resistant mutants appeared
and spread during competition experiments, we picked
four independent colony isolates from each of the two ge-
netic backgrounds in every replicate population. In cases
where only one genetic background was present at the end,
we took four colony isolates from that genetic background.
We then grew each colony isolate in 100ml of liquid
LB+MgSO4 for 3 h, before streaking it across a line of each
phage that had been previously dried onto an agar plate.
Isolates were scored resistant if there was no visible growth
inhibition after 24-h incubation (Buckling and Rainey 2002;
Brockhurst et al. 2007). Because phage-resistant mutants fre-
quently have a mucoid colony phenotype in these conditions
(Tazzyman and Hall 2015), we also scored whether each
colony isolate was mucoid or not.
Experimental Evolution in the Absence of Phages
We independently isolated three mucoid and three nonmu-
coid phage-resistant mutants from both the reference and
mutator genetic backgrounds, before propagating them in
the absence of phages (supplementary fig. S1,
Supplementary Material online). To do this we grew replicate
cultures of each genetic background in the +T4 treatment
before streaking them on agar, picking a single colony from
each population and testing for phage resistance by streaking
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assays as above. Colony isolates that were resistant to one or
both phages were purified by restreaking them twice, and
three mucoid and nonmucoid isolates from each genetic
background were randomly chosen. Each was then grown
for 2 h in phage-free liquid culture and frozen at 80 C.
We experimentally evolved these 12 phage-resistant mutants
in the absence of phages in the same conditions as above,
with three replicate selection lines for each ancestral genotype
(n = 36), for ten growth cycles in batch culture with 100-fold
dilution at each transfer (~66 generations), freezing samples
of each population every second transfer. We also included
three replicate selection lines each for the ancestral phage-
sensitive reference and mutator strains (n = 42 total). At the
end of the experiment, we tested for changes in phage resis-
tance, mucoidy, and competitive fitness as described below.
Quantifying Phage Resistance after Evolution in
Phage-Free Conditions
We quantified changes in phage resistance after ten growth
cycles in the absence of phages by measuring the reduction in
bacterial growth, RBG (Poullain et al. 2008; Hall et al. 2011),
attributable to phages in liquid cultures of each ancestral
genotype and evolved population. For a given assay, indepen-
dent cultures were grown in the presence and absence of
phages, and initial and final bacterial population densities
were estimated by taking OD at 600 nm using an M2
SpectraMax spectrophotometer (Molecular Devices,
Sunnyvale, CA). RBG was then calculated as ODwith phage/
ODwithout phage, so that RBG = 1 if phages had no effect on
bacterial growth, and RBG < 1 if bacterial growth was re-
duced by phages. We assayed RBG three times independently
for samples of every population taken every second transfer.
We also tested for changes in mucoidy by streaking each
population from each time point on agar and counting the
proportion of mucoid colonies.
Changes in Competitive Fitness due to Phage
Resistance and Evolution in the Absence of Phages
To test both whether phage resistance was associated with a
pleiotropic cost in terms of competitive fitness, and whether
that cost was ameliorated during evolution in the absence of
phages, we did pairwise competition assays for each phage-
resistant ancestor (n = 12), as well as a single clone derived
from each at the end of ten transfers of experimental evolu-
tion in the absence of phages (n = 12). We also assayed fitness
for the ancestral, phage-sensitive reference and mutator, plus
three clones derived from each that we isolated from inde-
pendently evolved populations at the end of the experiment.
These assays were done as above, except that they lasted a
single transfer and selection coefficients were estimated per
generation, taking the number of generations in each assay as
log2(Nfinal/Ninitial), where N is the total population size, allow-
ing us to estimate fitness w as 1+s relative to the reference
strain, after correction for the cost of the ara-marker
(Trindade et al. 2009). Additionally, we measured phage re-
sistance for each of these genotypes by RBG assays to test for
reversion of phage resistance. Finally, having observed
reversion of both mucoidy and phage resistance as early as
the second transfer of our experiment, we also isolated six
revertants (colony isolates that were mucoid at the beginning
but nonmucoid after two transfers) and measured competi-
tive fitness and resistance alongside the other isolates.
Testing for Re-Evolution of Mucoidy
We hypothesized that, following reversion of mucoidy in the
absence of phages, bacteria may be less likely to re-evolve
mucoidy upon subsequent re-exposure to the same phage
treatment that originally selected for mucoid mutants, com-
pared with control populations that had never encountered
the phages previously. We tested this by growing six replicate
populations of each of the six revertant genotypes from trans-
fer 10 (phage-sensitive nonmucoid isolates derived from
phage-resistant mucoid ancestors). We also included six rep-
licate populations of the reference strain in the same phage
treatment as used above to isolate resistant mutants. We
then plated each population and scored the fraction of
mucoid colonies.
Whole-Genome Resequencing
We sequenced the genomes of 32 bacterial strains: The an-
cestral reference and mutator strains, 12 phage-resistant mu-
tants used to initiate our evolution experiment (time point 0;
T0), 12 evolved clones from the end of the experiment (T10),
and 6 revertants (nonmucoid isolates derived from mucoid
phage-resistant clones) isolated after two transfers (T2) to
investigate in more detail the genetic basis of reversion of
phage resistance. Genomic DNA was extracted using
Qiagen’s Genomic DNA extraction buffers with 20/G
Genomic-tips. We typically obtained greater than 10 mg of
high quality DNA (average fragment sizes exceeding 20 kb).
DNA extracts were prepared for sequencing using NEBNext
Library Prep Kit for Illumina sequencers according to the
manufacturer’s recommendations with insert sizes of 400–
600 bp. Sequencing was performed on a Illumina HiSeq 2500
machines in paired-end mode of either 2 100 bp or 2 125
bp sequence lengths. Sequences were trimmed to remove
both Illumina specific adapters/primers and bad quality
bases in single reads using Trimmomatic v0.32 (Bolger et al.
2014); with these basic parameters ILLUMINACLIP: TruSeq3-
PE-2.fa:2:25:10 CROP:99 LEADING:30 TRAILING:25
SLIDINGWINDOW:4:25 MINLEN:36. Quality was assessed
before and after trimming using FastQC v0.11.2 (Andrews
2015). Finally, both trimmed paired and nonpaired reads
were mapped to the E. coli str. K-12 substr. MG1655 reference
genome (Blattner et al. 1997) using breseq v0.24rc5 (Barrick
et al. 2014; Deatherage and Barrick 2014). The ancestral se-
quences had five extra mutations compared with the K-12
reference, which served as internal positive controls and in-
dicated reliable resequencing results (supplementary table S2,
Supplementary Material online). These were all removed
prior to downstream statistical analyses. Given the strengths
and limitations of short resequencing we focus our analyses
on the following mutation categories: SNPs, insertions and
deletions, with the latter spanning regions up to several 10 kb,
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IS movements, and finally, small duplications, with the max-
imum close to the read lengths, that is, <125 bp.
Supplementary Material
Supplementary data, figures S1–S7 and tables S1–S4 are avail-
able at Molecular Biology and Evolution online (http://www.
mbe.oxfordjournals.org/).
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